PineBridge Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-56,827
Closed -$765K 1164
2018
Q4
$765K Sell
56,827
-20,047
-26% -$338K 0.02% 581
2018
Q3
$1.49M Buy
76,874
+3,800
+5% +$80.9K 0.03% 473
2018
Q2
$1.87M Sell
73,074
-6,319
-8% -$147K 0.05% 403
2018
Q1
$1.6M Buy
79,393
+19,732
+33% +$460K 0.04% 453
2017
Q4
$1.2M Sell
59,661
-3,928
-6% -$77.2K 0.03% 515
2017
Q3
$1.32M Buy
63,589
+517
+0.8% +$8.74K 0.03% 454
2017
Q2
$934K Buy
63,072
+57,411
+1,014% +$957K 0.02% 525
2017
Q1
$91K Buy
5,661
+175
+3% +$2.52K ﹤0.01% 945
2016
Q4
$69K Hold
5,486
﹤0.01% 1039
2016
Q3
$153K Buy
5,486
+884
+19% +$29.7K 0.01% 616
2016
Q2
$161K Buy
+4,602
New +$145K 0.01% 585

Other funds holding DPLO

PineBridge Investments's DPLO Position: Q1 2019 in Review

PineBridge Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2019, closing a stake of 56,827 shares — an estimated $765K sold.

PineBridge Investments first reported a position in DPLO in Q2 2016 and held it in 11 quarters. The position peaked at $1.87M in Q2 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • PineBridge Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2019 after selling out during the quarter.
  • PineBridge Investments sold 56,827 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $765K.
  • PineBridge Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 11 quarters.
  • PineBridge Investments's DIPLOMAT PHARMACY, INC. position peaked at $1.87M in Q2 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on PineBridge Investments's 13F filing for Q1 2019, filed 14 May 2019.